German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Uricosurics. |
| Generic Name : | Sulfinpyrazone [sulphinpyrazone] |
| Drug description : | Yellow s-c tablets marked GEIGY. |
| Presentation : | Tablets, sulfinpyrazone 100 mg , 200 mg . |
| Indications : | Chronic gout including tophaceous gout, recurrent gouty arthritis, hyperuricaemia. |
| Adult Dosage : | 100 - 200 mg daily with food increasing to 600 mg daily over two or three weeks. Maximum 800 mg daily. Maintenance, reduce to minimum effective dose. |
| Child Dosage : | Not recommended. |
| Contra Indications : | Known hypersensitivity to sulfinpyrazone and other pyrazole derivatives. Acute or history of peptic ulcers. Acute attacks of gout. Severe hepatic or renal dysfunction. Blood dyscrasias. Porphyria. Haemorrhagic diastheses. Anti-inflammatory induced allergies. |
| Special Precautions : | Impaired renal function, nephrolithiasis, renal colic. Latent or overt heart failure. Pregnancy, lactation. Check blood count and renal function regularly. Ensure adequate fluid intake. |
| Interactions : | Salicylates, NSAIDs, anticoagulants, hypoglycaemics, sulphonamides, penicillins, theophylline, phenytoin. |
| Adverse Reactions : | GI upset, bleeding and ulcers, renal and hepatic impairment, salt and water retention. Rash or |
| Manufacturer : | Sovereign |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org

Medical News Feed



